beta-Galactosidase-1/GLB1 Antibody (OTI1C9) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-70829PCP
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Canine, Monkey
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # OTI1C9
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length human recombinant protein of human GLB1(NP_001073279) produced in HEK293T cell.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for beta-Galactosidase-1/GLB1 Antibody (OTI1C9) [PerCP]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: beta-Galactosidase-1/GLB1
Alternate Names
betaGalactosidase1, EBP, ELNR1, GLB1, Lactase
Gene Symbol
GLB1
Additional beta-Galactosidase-1/GLB1 Products
Product Documents for beta-Galactosidase-1/GLB1 Antibody (OTI1C9) [PerCP]
Product Specific Notices for beta-Galactosidase-1/GLB1 Antibody (OTI1C9) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...